CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 420 enrolled
Drug / intervention
Fitmore Hip Stemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03411044
NCT03411044N/ACompleted
CompareCT.gov

Fitmore Hip Stem Post-Market Clinical Follow-Up (PMCF) Study

Zimmer Biomet·observational·Posted Jan 25, 2018·Updated Nov 5, 2024

In Brief

An observational study evaluating Fitmore Hip Stem for Osteoarthritis and 3 related conditions. Completed, enrolled 420 participants across 5 sites in 4 countries.

Detailed Summary

A multi-centre, non-comparative, prospective post-market clinical follow-up study to obtain survival, clinical and radiographic outcomes data on the Zimmer Fitmore Hip Stem.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Prosthesis Failure
CountriesGermany, Italy, Switzerland, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 25, 2018
Enrollment StartFeb 8, 2008
Primary CompletionJun 10, 2023
TodayJul 2, 2026
Enrollment to primary: 15.3 yearsPosted 8.4 years ago

Interventions

Fitmore Hip Stemdevice